Showing 1 - 7 results of 7 for search 'Piers Blombery', query time: 0.05s
Refine Results
-
1
Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide by Ing S. Tiong, William S. Stevenson, Meaghan Wall, Yan Zhuang Yap, John F. Seymour, Melita Kenealy, Piers Blombery, the Australasian Leukaemia & Lymphoma Group
Published 2023-11-01
Article -
2
Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia by Sean Harrop, Phillip C. Nguyen, David Byrne, Clarissa Wilson, Georgina L. Ryland, Tamia Nguyen, Mary Ann Anderson, Seong Lin Khaw, Michelle Martin, Ing Soo Tiong, Elaine Sanij, Piers Blombery
Published 2023-11-01
Article -
3
Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS by Gareth P. Gregory, Michael Dickinson, Costas K. Yannakou, Jonathan Wong, Piers Blombery, Greg Corboy, Lev Kats, Tim M.E. Crozier, Beena Kumar, H. Miles Prince, Stephen S. Opat, Jake Shortt
Published 2019-04-01
Article -
4
Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity by Piers Blombery, Vahid Pazhakh, Adriana S. Albuquerque, Jesmeen Maimaris, Lingge Tu, Brenda Briones Miranda, Florence Evans, Ella R. Thompson, Ben Carpenter, Ian Proctor, Julie A. Curtin, Jonathan Lambert, Siobhan O. Burns, Graham J. Lieschke
Published 2023-05-01
Article -
5
P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALY... by Adrian Minson, Emma Verner, Pratyush Giri, Shu Min Wong, Sumita Ratnasingam, Jason Butler, Wojciech Janowski, Matthew Ku, Chan Cheah, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas Yannakou, Paul Neeson, Javad Saghebi, Piers Blombery, Molly Robertson, Lei Shong Lau, Jing Xie, John Seymour, Michael Dickinson
Published 2023-08-01
Article -
6
S176: FUNCTIONAL AND ANTIGEN-SPECIFIC CHARACTERIZATION OF IMMUNE CELLS AT THE SINGLE-CELL LEVEL REVEALS CONVERGENCE OF ADAPTIVE AND INNATE IMMUNITY IN IMMUNE APLASTIC ANEMIA by Jani Huuhtanen, Sofie Lundgren, Mikko Keränen, Xingim Feng, Alina Dulau-Florea, Bhavisha Patel, Yoshitaka Zaimoku, Cassandra Kerr, Emmi Jokinen, Markus Heinonen, Hanna Rajala, Sanna Siitonen, Freja Ebeling, Georgina Ryland, Lucy Fox, Piers Blombery, Eva Hellström-Lindberg, Jaroslaw P. Maciejewski, Neal S. Young, Harri Lähdesmäki, Satu Mustjoki
Published 2023-08-01
Article -
7
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-... by Stephane Heritier, Alisa Higgins, Piers Blombery, Robin Filshie, Paul Lacaze, Kate Wilson, William Stevenson, Lauren Young, Zoe McQuilten, Jennifer Curnow, Lucy Fox, Vanessa Fox, Ilona Cunningham, Devendra K Hiwase, Frank Firkin, Kylie Mason, Anthony K Mills, Dominic Pepperell, Sushrut Patil, Jeff Szer, Neil Waters, Stephen Ting, Erica Wood
Published 2024-01-01
Article